Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cel-Sci Corporation (CVM) vs Kyntra Bio Inc (KYNB)

Cel-Sci Corporation and Kyntra Bio Inc are both Biotechnology companies. Cel-Sci Corporation and Kyntra Bio Inc are of similar size ($30.3M and $28.3M). Cel-Sci Corporation has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.2×. Cel-Sci Corporation grew revenue faster over the last twelve months: 20.8% against −37.2%. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs −169.6%). Across the 17 metrics below, Kyntra Bio Inc leads on 11 and Cel-Sci Corporation on 6.

Valuation

Metric CVM KYNB Biotechnology median
P/E n/m 0.15 7.88
P/S 36.22 6.08 11.47
P/B 1.85 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 34.83 18.18 10.73
Earnings yield (68.40%) 652.74% (28.84%)
Free cash flow yield (83.02%) (135.59%) (23.03%)

Profitability

Metric CVM KYNB Biotechnology median
Gross margin 0.00% 6.28% 65.16%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity (252.53%) (157.83%) (57.72%)
Return on assets (108.91%) 131.26% (49.22%)
Return on invested capital (169.59%) 0.00% 0.00%

Growth

Metric CVM KYNB Biotechnology median
Revenue growth (TTM) 20.75% (37.15%) 5.64%
EPS growth (last fiscal year) 59.06% 478.08% —
Revenue growth, 5-year CAGR 16.18% (48.42%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CVM KYNB Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 1.48 2.69 4.73
Net debt to EBITDA 0.25 1.97 0.96

Dividend

Metric CVM KYNB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CVM KYNB Biotechnology median
Market cap 30.25m 28.34m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack